Wicki Andreas's Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Aug 10, 2022
- Accession no.
- 0001104659-22-088896
- Filed
- Aug 10, 2022
- Trade date
- Aug 8-10, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $31.1M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wicki AndreasCIK 0001511472 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2022 | Common Stock | SSaleDisposed | −486,360 | $53.94 | −$26,234,258.4 | 3,104,282 | Indirect | |
| Aug 9, 2022 | Common Stock | SSaleDisposed | −20,745 | $53.67 | −$1,113,384.15 | 3,083,537 | Indirect | |
| Aug 10, 2022 | Common Stock | SSaleDisposed | −71,447 | $52.61 | −$3,758,826.67 | 3,012,090 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.